Researchers developed a wirelessly powered temporary pacemaker that breaks down in the body after use. The device can generate enough power to pace a human heart without causing damage or inflammation.
NIH is funding projects to identify ways of safely returning students and staff to in-person school in areas with vulnerable and underserved populations. part of NIH’s Rapid Acceleration of Diagnostics Underserved Populations (RADx-UP) program.
A diet higher in fatty fish helped frequent migraine sufferers reduce the frequency of headaches and intensity of pain compared to participants on a diet higher in vegetable-based fats and oils, according to a new study.
Adolescent marijuana use and binge drinking did not significantly change during the Covid-19 pandemic, despite record decreases in the substances’ perceived availability, according to a survey of 12th graders in the U.S. The NIDA-funded research was led by investigators at the University of Michigan, Ann Arbor.
In an NIAID-funded study, the immune response to the single-shot Janssen/Johnson & Johnson Covid-19 vaccine remained robust against variants.
An international coalition of eye researchers used machine learning to classify 25 of the most common types of uveitis, a collection of more than 30 diseases characterized by inflammation inside the eye.
New findings suggest there is no difference in cognitive outcomes at age 2 among children of healthy women and children of women with epilepsy who took antiseizure medication during pregnancy.
A team of researchers funded in part by NIAID and NCI created a vaccine that protects against a range of coronaviruses, including SARS-CoV-2.
New research shows that an innovative cardiac rehabilitation intervention started earlier and more custom-tailored to the individual improved physical function, frailty, quality-of-life and depression in hospitalized heart failure patients, compared to traditional rehab programs. These findings, supported by NIA, were published in the New England Journal of Medicine.
Women taking 1,000 mg of docosohexanoic acid (DHA) daily in the last half of pregnancy had a lower rate of early preterm birth than women who took the standard 200 mg dose, according to an NICHD-funded study that appears in EClinicalMedicine.